Impact of scheduling on the practice of medicine and biomedical research

Jaffe, Jerome H.

doi:10.1016/0376-8716(85)90070-5

Cited by 14 publications

(5 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Misuse of tramadol with suicidal ideation was not reported in our surveys, and does not seem to be an issue in the discussion on scheduling in Germany. In addition, the disadvantages of scheduling have to be considered (40, 41). Physicians might be more reluctant to prescribe with higher legal or administrative barriers such as filling out triplicate forms.…”

Section: Discussionmentioning

confidence: 99%

Topical Review on the Abuse and Misuse Potential of Tramadol and Tilidine in Germany

et al. 2013

View full text Add to dashboard Cite

In conclusion, the subcommittee of the expert advisory committee found a low potential for misuse, abuse, and dependency for tramadol, and a low prevalence in clinical practice. Considerable less information is available for the combination of tilidine and naloxone. However, the cumulation of evidence indicated a higher risk of misuse, abuse, and dependency for tilidine/naloxone solution, but not for slow-release tablets.

show abstract

Section: Discussionmentioning

confidence: 99%

Topical Review on the Abuse and Misuse Potential of Tramadol and Tilidine in Germany

et al. 2013

View full text Add to dashboard Cite

show abstract

“…Several factors exacerbated con›ict between the clinic and laboratory in ways that made clinicians relatively uninterested in treating drug addiction. Once blamed for addicting patients, physicians began to avoid or underprescribe opiates even to patients in need of them (Jaffe 1985). So-called selfadministration studies are discussed further in chapter 4 in the present book.…”

Section: Conclusion / 233mentioning

confidence: 97%

Discovering Addiction

Campbell¹

2007

135

View full text Add to dashboard Cite

Discovering Addiction brings the history of human and animal experimentation in addiction science into the present with a wealth of archival research and dozens of oral-history interviews with addiction researchers. Professor Campbell examines the birth of addiction science---the National Academy of Sciences's project to find a pharmacological fix for narcotics addiction in the late 1930s---and then explores the human and primate experimentation involved in the succeeding studies of the "opium problem," revealing how addiction science became "brain science" by the 1990s. Psychoactive drugs have always had multiple personalities---some cause social problems; others solve them---and the study of these drugs involves similar contradictions. Discovering Addiction enriches discussions of bioethics by exploring controversial topics, including the federal prison research that took place in the 1970s---a still unresolved debate that continues to divide the research community---and the effect of new rules regarding informed consent and the calculus of risk and benefit. This fascinating volume is both an informative history and a thought-provoking guide that asks whether it is possible to differentiate between ethical and unethical research by looking closely at how science is made. Nancy D. Campbell is Associate Professor of Science and Technology Studies at Rensselaer Polytechnic Institute and the author of Using Women: Gender, Drug Policy, and Social Justice. "Compelling and original, lively and engaging---Discovering Addiction opens up new ways of thinking about drug policy as well as the historical discourses of addiction." ---Carol Stabile, University of Wisconsin--Milwaukee Also available: Student Bodies: The Influence of Student Health Services in American Society and Medicine, by Heather Munro Prescott Illness and the Limits of Expression, by Kathlyn Conway White Coat, Clenched Fist: The Political Education of an American Physician, by Fitzhugh Mullan

show abstract

“…After relevant federal agencies were combined into the Drug Enforcement Administration in 1973, Congress alleviated public concern over drug use by ratcheting up penalties for possession through CSA amendments, including the reintroduction of mandatory minimum sentences during the late 1980s crack epidemic. The CSA also affected many doctors, who, fearing legal oversight and fostering addiction, scaled back pain reliever prescription for decades [10]. Awareness of this trend, supplemented with huge campaigns by the pharmaceutical industry, led to more liberal prescription, a rise in "doctor shopping," and the creation of "Oxycontin Superhighways" in the 1990s and 2000s.…”

Section: Historical Contextmentioning

confidence: 99%

Missing Data, Moral Eyesores, and Marginalized People: Opposition to Needle Exchange and Harm Reduction in Drug Policy

Bridge¹

2014

Proceedings of the 4th World Sustainability Forum

View full text Add to dashboard Cite

An ongoing opiate use epidemic has given drug use and policy new importance in public discourse. This paper provides an historical overview of American drug history, questioning how policy became and remains generally punitive. But many opponents of imposed abstinence consider a certain amount of addiction unavoidable and advocate for "harm reduction," or to mitigate the personal and social consequences of some inevitable drug use. The second half of this paper considers an especially controversial idea in harm reduction, needle exchanges, and outlines the arguments against wider implementation of these programs.

show abstract

Impact of scheduling on the practice of medicine and biomedical research

Cited by 14 publications

References 20 publications

Topical Review on the Abuse and Misuse Potential of Tramadol and Tilidine in Germany

Topical Review on the Abuse and Misuse Potential of Tramadol and Tilidine in Germany

Discovering Addiction

Missing Data, Moral Eyesores, and Marginalized People: Opposition to Needle Exchange and Harm Reduction in Drug Policy

Contact Info

Product

Resources

About